What’s the import and export situation of medical dressing in China? And what are the prospects of this industry? Today, pharmaceutical and medical devices online platform, Ddu, brings you the breakdown with our Medical Dressing Market Analysis Report.
The US Food and Drug Administration (FDA) has cleared AUM Cardiovascular’s acoustic and electrocardiogram (ECG) device called CADence to aid detection of physiological and pathological heart murmurs.
UC Davis Health researchers have discovered how by-products of the digestion of dietary fiber by gut microbes act as the right fuel to help intestinal cells maintain gut health.
A report examining the European venture landscape for health and biotech firms over the first half of 2017 has found that there is a continuing positive environment for venture funding and M&A in the sector.
Allied Academies invites all the participants from all over the world to attend 7th International Conference on Dementia & Care Practice at Toronto, Canada.
Roche has agreed to out-license certain rights to its invesitgational atropic dermatitis drug lebrikizumab to Demira in a deal that could be worth more than $1.4 billion.
According to official Ddu news, the leading global pharmaceutical and medical device B2B online platform and SGS-CSTC (Standards Technical Services Co., Ltd.) will be calling a press conference in Shenzhen, China, on August 18, 2017 to launch their strategic partnership on credit verification and kick off the Ddu Credit Verification Service officially.
With the rapid development of modern computer and signal integration technology, construction of digitalization in medical imaging devices has become a new trend. CR / DR, multi-slice spiral CT, Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET) have been applied in clinical practices and play an increasingly important role.
Ddu, the leading global pharmaceutical and medical device B2B online platform attended AACC with products of high priority members to expand the American market for users.
In the featured translational article in the August issue of The Journal of Nuclear Medicine, researchers at the University of Michigan demonstrate the potential of a new PET tracer, Carbon-11 labeled sarcosine (11C-sarcosine), for imaging prostate cancer, and set the stage for its possible use in monitoring other cancers.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.